Intended for healthcare professionals


Data on neuraminidase inhibitors were made available

BMJ 2004; 328 doi: (Published 26 February 2004) Cite this as: BMJ 2004;328:523
  1. Zoya Panahloo, senior medical adviser (
  1. United Kingdom F Hoffmann La Roche, Welwyn Garden City, Hertfordshire AL7 3AY zoya.

    EDITOR—In response to Symmonds et al,1 F Hoffmann-La Roche would like to clarify that data from studies WV15759/WV15871 were made available to the National Institute for Clinical Excellence.

    These were double blind, placebo controlled trials, …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription